Genetic Mutations in Familial Hypomagnesaemia with Hypercalciuria
Author Information
Author(s): Geeta Hampson, Konrad Martin, John Scoble
Primary Institution: Department of Chemical Pathology, St Thomas Hospital, London, UK
Hypothesis
The study investigates the genetic mutations in the CLDN16 gene responsible for familial hypomagnesaemia with hypercalciuria and nephrocalcinosis.
Conclusion
The identified mutations in the CLDN16 gene lead to complete loss of function of the protein, resulting in severe renal complications in the affected siblings.
Supporting Evidence
- Both affected siblings exhibited extensive nephrocalcinosis and renal impairment.
- Mutation analysis revealed two heterozygous mutations in the CLDN16 gene.
- The identified mutations resulted in complete loss of function of the claudin 16 protein.
- Renal transplantation was required for both affected siblings due to disease progression.
Takeaway
This study looks at two siblings who have a rare kidney problem caused by changes in their genes, which made it hard for their bodies to handle magnesium and calcium.
Methodology
The study involved clinical, biochemical, and genetic analyses of two siblings diagnosed with FHHNC.
Limitations
The study is limited to a small family cohort and may not represent the broader population with FHHNC.
Participant Demographics
The participants are two siblings aged 7 and 18 months, both of Caucasian descent, with unaffected parents and one unaffected sibling.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website